ArticleAnnals of translational medicine2022

Efficacy and safety of combined treatment with pembrolizumab in patients with locally advanced or metastatic esophageal squamous cell carcinoma in the real world.

Pei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.